Sudipta Das
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sudipta Das has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Andrew Beppu
Department of Medicine, University of California San Diego, La Jolla, Calif
4 shared publications- David H. Broide
Department of Medicine, University of California San Diego, La Jolla, CA, 92093-0635, USA
4 shared publications Marina Miller
Department of Medicine, University of California San Diego, La Jolla, Calif
4 shared publications- Anurag Agrawal
Trivedi School of Biosciences, Ashoka University, Sonepat, India
3 shared publications Balaram Ghosh
Molecular Immunogenetics Laboratory, CSIR-Institute of Genomics and Integrative Biology, Delhi, India
3 shared publicationsPeter Rosenthal
Department of Medicine, University of California San Diego, La Jolla, Calif
3 shared publications
Latest Publications
- 1 January 2018
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 141 (1) , 329-338.e12
β2 integrins rather than β1 integrins mediate Alternaria-induced group 2 innate lymphoid cell trafficking to the lung
- 1 January 2018
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 141 (1) , 329-338.e12
β2 integrins rather than β1 integrins mediate Alternaria-induced group 2 innate lymphoid cell trafficking to the lung
- 1 October 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (4) , 1192-1195.e5
Regulatory B cells and T follicular helper cells are reduced in allergic rhinitis
- 1 October 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (4) , 1192-1195.e5
Regulatory B cells and T follicular helper cells are reduced in allergic rhinitis
- 1 August 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (2) , 596-599.e4
Segmental allergen challenge increases levels of airway follistatin-like 1 in patients with asthma
- 1 August 2016
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 138 (2) , 596-599.e4
Segmental allergen challenge increases levels of airway follistatin-like 1 in patients with asthma
- Open Access
- 1 January 2016
- Published by Scitechnol Biosoft Pvt. Ltd. in Insights in Allergy Asthma & Bronchitis
- Vol. 2 (1)
Why is Chromosome 17q21 linked to Asthma?
Asthma is an inflammatory disorder of the airways associated with increased airway responsiveness and airway remodeling. Several genome wide association studies (GWAS) and non-GWAS studies have demonstrated a strong genetic linkage of chromosome 17q21 genes with asthma in populations of diverse ethnic backgrounds. In particular, SNPs in the 17q21 region are found within a large linkage disequilibrium (LD) block that contains not only the orosomucoid like-3 (ORMDL3) gene, but also includes other 17q21 genes i.e. gasdermin B (GSDMB), IKAROS family zinc finger 3 (IKZF3), and zona pellucida binding protein 2 (ZPBP2). Studies of mice expressing increased levels of the human ORMDL3 gene have demonstrated that these mice have spontaneous increased airway remodeling and airway responsiveness in the absence of airway inflammation. Further functional studies are needed to investigate whether some or all of these four genes could contribute to the pathogenesis of asthma.
- 1 January 2016
- Published by Scitechnol Biosoft Pvt. Ltd. in Insights in Allergy Asthma & Bronchitis
- Vol. 2 (1)
Open AccessWhy is Chromosome 17q21 linked to Asthma?
Asthma is an inflammatory disorder of the airways associated with increased airway responsiveness and airway remodeling. Several genome wide association studies (GWAS) and non-GWAS studies have demonstrated a strong genetic linkage of chromosome 17q21 genes with asthma in populations of diverse ethnic backgrounds. In particular, SNPs in the 17q21 region are found within a large linkage disequilibrium (LD) block that contains not only the orosomucoid like-3 (ORMDL3) gene, but also includes other 17q21 genes i.e. gasdermin B (GSDMB), IKAROS family zinc finger 3 (IKZF3), and zona pellucida binding protein 2 (ZPBP2). Studies of mice expressing increased levels of the human ORMDL3 gene have demonstrated that these mice have spontaneous increased airway remodeling and airway responsiveness in the absence of airway inflammation. Further functional studies are needed to investigate whether some or all of these four genes could contribute to the pathogenesis of asthma.
- Open Access
- 15 October 2015
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 195 (8) , 3546-3556
Fstl1 Promotes Asthmatic Airway Remodeling by Inducing Oncostatin M
Chronic asthma is associated with airway remodeling and decline in lung function. In this article, we show that follistatin-like 1 (Fstl1), a mediator not previously associated with asthma, is highly expressed by macrophages in the lungs of humans with severe asthma. Chronic allergen-challenged Lys-Cretg /Fstl1Δ/Δ mice in whom Fstl1 is inactivated in macrophages/myeloid cells had significantly reduced airway remodeling and reduced levels of oncostatin M (OSM), a cytokine previously not known to be regulated by Fstl1. The importance of the Fstl1 induction of OSM to airway remodeling was demonstrated in murine studies in which administration of Fstl1 induced airway remodeling and increased OSM, whereas administration of an anti-OSM Ab blocked the effect of Fstl1 on inducing airway remodeling, eosinophilic airway inflammation, and airway hyperresponsiveness, all cardinal features of asthma. Overall, these studies demonstrate that the Fstl1/OSM pathway may be a novel pathway to inhibit airway remodeling in severe human asthma.
- 15 October 2015
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 195 (8) , 3546-3556
Open AccessFstl1 Promotes Asthmatic Airway Remodeling by Inducing Oncostatin M
Chronic asthma is associated with airway remodeling and decline in lung function. In this article, we show that follistatin-like 1 (Fstl1), a mediator not previously associated with asthma, is highly expressed by macrophages in the lungs of humans with severe asthma. Chronic allergen-challenged Lys-Cretg /Fstl1Δ/Δ mice in whom Fstl1 is inactivated in macrophages/myeloid cells had significantly reduced airway remodeling and reduced levels of oncostatin M (OSM), a cytokine previously not known to be regulated by Fstl1. The importance of the Fstl1 induction of OSM to airway remodeling was demonstrated in murine studies in which administration of Fstl1 induced airway remodeling and increased OSM, whereas administration of an anti-OSM Ab blocked the effect of Fstl1 on inducing airway remodeling, eosinophilic airway inflammation, and airway hyperresponsiveness, all cardinal features of asthma. Overall, these studies demonstrate that the Fstl1/OSM pathway may be a novel pathway to inhibit airway remodeling in severe human asthma.
- Open Access
- 23 July 2015
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 43 (16) , 8057-8065
Altered expression and editing of miRNA-100 regulates iTreg differentiation
RNA editing of miRNAs, especially in the seed region, adds another layer to miRNA mediated gene regulation which can modify its targets, altering cellular signaling involved in important processes such as differentiation. In this study, we have explored the role of miRNA editing in CD4+ T cell differentiation. CD4+ T cells are an integral component of the adaptive immune system. Naïve CD4+ T cells, on encountering an antigen, get differentiated either into inflammatory subtypes like Th1, Th2 or Th17, or into immunosuppressive subtype Treg, depending on the cytokine milieu. We found C-to-U editing at fifth position of mature miR-100, specifically in Treg. The C-to-U editing of miR-100 is functionally associated with at least one biologically relevant target change, from MTOR to SMAD2. Treg cell polarization by TGFβ1 was reduced by both edited and unedited miR-100 mimics, but percentage of Treg in PBMCs was only reduced by edited miR-100 mimics, suggesting a model in which de-repression of MTOR due to loss of unedited mir-100, promotes tolerogenic signaling, while gain of edited miR-100 represses SMAD2, thereby limiting the Treg. Such delicately counterbalanced systems are a hallmark of immune plasticity and we propose that miR-100 editing is a novel mechanism toward this end.
- 23 July 2015
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 43 (16) , 8057-8065
Open AccessAltered expression and editing of miRNA-100 regulates iTreg differentiation
RNA editing of miRNAs, especially in the seed region, adds another layer to miRNA mediated gene regulation which can modify its targets, altering cellular signaling involved in important processes such as differentiation. In this study, we have explored the role of miRNA editing in CD4+ T cell differentiation. CD4+ T cells are an integral component of the adaptive immune system. Naïve CD4+ T cells, on encountering an antigen, get differentiated either into inflammatory subtypes like Th1, Th2 or Th17, or into immunosuppressive subtype Treg, depending on the cytokine milieu. We found C-to-U editing at fifth position of mature miR-100, specifically in Treg. The C-to-U editing of miR-100 is functionally associated with at least one biologically relevant target change, from MTOR to SMAD2. Treg cell polarization by TGFβ1 was reduced by both edited and unedited miR-100 mimics, but percentage of Treg in PBMCs was only reduced by edited miR-100 mimics, suggesting a model in which de-repression of MTOR due to loss of unedited mir-100, promotes tolerogenic signaling, while gain of edited miR-100 represses SMAD2, thereby limiting the Treg. Such delicately counterbalanced systems are a hallmark of immune plasticity and we propose that miR-100 editing is a novel mechanism toward this end.
- 21 May 2015
- Published by Springer Nature in Journal of Human Genetics
- Vol. 60 (8) , 443-448
Genetic association of key Th1/Th2 pathway candidate genes, IRF2, IL6, IFNGR2, STAT4 and IL4RA, with atopic asthma in the Indian population
Asthma is a complex, multifactorial disease resulting due to dysregulated immune responses. Genetic factors contribute significantly to asthma pathogenesis, and identification of these factors is one of the major goals in understanding the disease. Th1/Th2 helper differentiation has a critical role in modulating the phenotypes associated with atopic asthma. This study was aimed at identifying genetic modifiers of asthma in selected genes involved in T helper differentiation. A total of 354 single-nucleotide polymorphisms (SNPs) in 33 candidate genes were genotyped in a case-control cohort (cases=147, controls=199) and families (n=247) using Illumina's Golden Gate Assay. Five SNPs, rs3733475A/C (IRF2), rs2069832A/G (IL6), rs2012075G/A (IFNGR2) and rs1400656G/A (STAT4) and rs1805011C/A (IL4RA) were found to be associated with asthma in family based as well as in case-control analyses (P=0.002, P=0.001, P=0.004, P=0.003 and P=0.001, respectively). Interestingly, the minor alleles at these loci showed a protective effect. A five loci haplotype, TAACG, in IRF2 gene, was significantly associated with asthma in families (P=1.1 × 10(-6)) and in case-control cohort (P=0.01). In conclusion, our studies led to identification of some key candidate genes, namely IRF2, IL6, IFNGR2, STAT4 and IL4RA that modulate genetic susceptibility to asthma in the Indian population. Also, this is the first report of independent association of IL6 gene polymorphism with atopic asthma.
- 21 May 2015
- Published by Springer Nature in Journal of Human Genetics
- Vol. 60 (8) , 443-448
Genetic association of key Th1/Th2 pathway candidate genes, IRF2, IL6, IFNGR2, STAT4 and IL4RA, with atopic asthma in the Indian population
Asthma is a complex, multifactorial disease resulting due to dysregulated immune responses. Genetic factors contribute significantly to asthma pathogenesis, and identification of these factors is one of the major goals in understanding the disease. Th1/Th2 helper differentiation has a critical role in modulating the phenotypes associated with atopic asthma. This study was aimed at identifying genetic modifiers of asthma in selected genes involved in T helper differentiation. A total of 354 single-nucleotide polymorphisms (SNPs) in 33 candidate genes were genotyped in a case-control cohort (cases=147, controls=199) and families (n=247) using Illumina's Golden Gate Assay. Five SNPs, rs3733475A/C (IRF2), rs2069832A/G (IL6), rs2012075G/A (IFNGR2) and rs1400656G/A (STAT4) and rs1805011C/A (IL4RA) were found to be associated with asthma in family based as well as in case-control analyses (P=0.002, P=0.001, P=0.004, P=0.003 and P=0.001, respectively). Interestingly, the minor alleles at these loci showed a protective effect. A five loci haplotype, TAACG, in IRF2 gene, was significantly associated with asthma in families (P=1.1 × 10(-6)) and in case-control cohort (P=0.01). In conclusion, our studies led to identification of some key candidate genes, namely IRF2, IL6, IFNGR2, STAT4 and IL4RA that modulate genetic susceptibility to asthma in the Indian population. Also, this is the first report of independent association of IL6 gene polymorphism with atopic asthma.
- 1 May 2014
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 50 (5) , 882-892
MicroRNA-326 Regulates Profibrotic Functions of Transforming Growth Factor-β in Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a fatal disorder resulting from the progressive remodeling of lungs, with no known effective treatment. Although transforming growth factor (TGF)-β has a well-established role in lung fibrosis, clinical experience with neutralizing antibodies to TGF-β has been disappointing, and strategies to directly suppress TGF-β1 secretion are needed. In this study we used a combination of in silico, in vitro, and in vivo approaches to identify microRNAs involved in TGF-β1 regulation and to validate the role of miR-326 in pulmonary fibrosis.We show that hsa-miR-326 regulates TGF-β1 expression and that hsa-miR-326 levels are inversely correlated to TGF-β1 protein levels in multiple human cell lines. The increase in TGF-β1 expression during the progression of bleomycin-induced lung fibrosis in mice was associated with loss of mmu-miR-326. Restoration of mmu-miR-326 levels by intranasal delivery of miR-326 mimics was sufficient to inhibit TGF-β1 expression and attenuate the fibrotic response. Moreover, human IPF lung specimens had markedly diminished miR-326 expression as compared with nonfibrotic lungs. Additional targets of miR-326 controlling TGF-β signaling and fibrosis-related pathways were identified, and miR-326 was found to down-regulate profibrotic genes, such as Ets1, Smad3, and matrix metalloproteinase 9, whereas it up-regulates antifibrotic genes, such as Smad7. Our results suggest for the first time that miR-326 plays a key role in regulating TGF-β1 expression and other profibrotic genes and could be useful in developing better therapeutic strategies for alleviating lung fibrosis.
- 1 May 2014
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 50 (5) , 882-892
MicroRNA-326 Regulates Profibrotic Functions of Transforming Growth Factor-β in Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a fatal disorder resulting from the progressive remodeling of lungs, with no known effective treatment. Although transforming growth factor (TGF)-β has a well-established role in lung fibrosis, clinical experience with neutralizing antibodies to TGF-β has been disappointing, and strategies to directly suppress TGF-β1 secretion are needed. In this study we used a combination of in silico, in vitro, and in vivo approaches to identify microRNAs involved in TGF-β1 regulation and to validate the role of miR-326 in pulmonary fibrosis.We show that hsa-miR-326 regulates TGF-β1 expression and that hsa-miR-326 levels are inversely correlated to TGF-β1 protein levels in multiple human cell lines. The increase in TGF-β1 expression during the progression of bleomycin-induced lung fibrosis in mice was associated with loss of mmu-miR-326. Restoration of mmu-miR-326 levels by intranasal delivery of miR-326 mimics was sufficient to inhibit TGF-β1 expression and attenuate the fibrotic response. Moreover, human IPF lung specimens had markedly diminished miR-326 expression as compared with nonfibrotic lungs. Additional targets of miR-326 controlling TGF-β signaling and fibrosis-related pathways were identified, and miR-326 was found to down-regulate profibrotic genes, such as Ets1, Smad3, and matrix metalloproteinase 9, whereas it up-regulates antifibrotic genes, such as Smad7. Our results suggest for the first time that miR-326 plays a key role in regulating TGF-β1 expression and other profibrotic genes and could be useful in developing better therapeutic strategies for alleviating lung fibrosis.
- 1 July 2011
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 128 (1) , 239-242.e3
Monocyte chemotactic protein (MCP3) promoter polymorphism is associated with atopic asthma in the Indian population
- 1 July 2011
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 128 (1) , 239-242.e3
Monocyte chemotactic protein (MCP3) promoter polymorphism is associated with atopic asthma in the Indian population
- 1 July 2008
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 122 (1) , 202-208.e7
Genetic association of acidic mammalian chitinase with atopic asthma and serum total IgE levels
- 1 July 2008
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 122 (1) , 202-208.e7
Genetic association of acidic mammalian chitinase with atopic asthma and serum total IgE levels